|
1
|
Rosen LE and Gattuso P: Neuroendocrine
tumors of the breast. Arch Pathol Lab Med. 141:1577–1581. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rakha E and Tan PH: Head to head: Do
neuroendocrine tumours in the breast truly exist? Histopathology.
81:2–14. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lebeau A and Denkert C: Updated WHO
classification of tumors of the breast: The most important changes.
Der Pathologe. 42:270–280. 2021.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pareja F, Vahdatinia M, Marchio C, Lee
SSK, Da Cruz Paula A, Derakhshan F, da Silva EM, Selenica P, Dopeso
H, et al: Neuroendocrine tumours of the breast: A genomic
comparison with mucinous breast cancers and neuroendocrine tumours
of other anatomic sites. J Clin Pathol. 75:10–17. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salemis NS: Primary neuroendocrine
carcinoma of the breast: A rare presentation and review of the
literature. Intractable Rare Dis Res. 9:233–246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Spak DA, Plaxco JS, Santiago L, Dryden MJ
and Dogan BE: BI-RADS® fifth edition: A summary of
changes. Diagn Interv Imaging. 98:179–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Feyrter F and Hartmann G: On the carcinoid
growth form of the carcinoma mammae, especially the carcinoma
solidum (gelatinosum) mammae. Frankf Z Pathol. 73:24–39. 1963.(In
German). PubMed/NCBI
|
|
8
|
Cubilla AL and Woodruff JM: Primary
carcinoid tumor of the breast: A report of eight patients. Am J
Surg Pathol. 1:283–292. 1977. View Article : Google Scholar
|
|
9
|
Bussolati G, Gugliotta P, Sapino A, Eusebi
V and Lloyd RV: Chromogranin-reactive endocrine cells in
argyrophilic carcinomas (“carcinoids”) and normal tissue of the
breast. Am J Pathol. 120:186–192. 1985.PubMed/NCBI
|
|
10
|
Sapino A and Bussolati G: Is detection of
endocrine cells in breast adenocarcinoma of diagnostic and clinical
significance? Histopathology. 40:211–214. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
John E, Fattaneh N, Tavassoli A and
Devilee A: Pathology and genetics of tumors of the breast and
female genital organs. Iarc; 2003
|
|
12
|
Eymard H, Pittella J and Alfredo JAB: The
new WHO classification of breast tumors. J Brasileiro de Patologia
e Medicina Laboratorial. 48:406–407. 2012.
|
|
13
|
Tan PH, Ellis I, Allison K, Brogi E, Fox
SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, et al: The
2019 WHO classification of tumors of the breast. Histopathology.
77:181–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Uccella S, Finzi G, Sessa F and La Rosa S:
On the endless dilemma of neuroendocrine neoplasms of the breast: A
journey through concepts and entities. Endocr Pathol. 31:321–329.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
La Rosa S and Uccella S: Classification of
neuroendocrine neoplasms: Lights and shadows. Rev Endocr Metab
Disord. 22:527–538. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun H, Dai S, Xu J, Liu L, Yu J and Sun T:
Primary neuroendocrine tumor of the breast: Current understanding
and future perspectives. Front Oncol. 12:8484852022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kherbek H, Skef J, Kherbek S, Abdulrahman
SA, Alshehabi Z and Zahlouk N: Primary neuroendocrine carcinoma of
the breast with paraneoplastic thrombocytosis; a rare case report.
Ann Med Surg (Lond). 77:1036642022.PubMed/NCBI
|
|
18
|
Wang J, Wang X, Du W, Guo Y, Yang X, Pan J
and Yin L: Primary neuroendocrine carcinoma of the breast with
markedly elevated alpha-fetoprotein: A case report. Transl Cancer
Res. 10:2503–2508. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Q, He L, Lv W and Wang N:
Neuroendocrine carcinoma of the breast with hyperprolactinemia:
Report of two cases and a minireview. Int J Clin Exp Pathol.
13:1457–1462. 2020.PubMed/NCBI
|
|
20
|
Lavigne M, Menet E, Tille JC, Lae M,
Fuhrmann L, Bonneau C, Deniziaut G, Melaabi S, Ng CCK, Marchiò C,
et al: Comprehensive clinical and molecular analyses of
neuroendocrine carcinomas of the breast. Modern Pathol. 31:68–82.
2018. View Article : Google Scholar
|
|
21
|
Kayadibi Y, Erginoz E, Cavus GH, Kurt SA,
Ozturk T and Velidedeoglu M: Primary neuroendocrine carcinomas of
the breast and neuroendocrine differentiated breast cancers:
Relationship between histopathological and radiological features.
Eur J Radiol. 147:1101482022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park YM, Wu Y, Wei W and Yang WT: Primary
neuroendocrine carcinoma of the breast: Clinical, imaging, and
histologic features. Am J Roentgenol. 203:W221–W230. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang ED, Kim MK, Kim JS and Whang IY:
Primary neuroendocrine tumor of the breast: Imaging features.
Korean J Radiol. 14:395–399. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hörsch D, Schmid KW, Anlauf M, Darwiche K,
Denecke T, Baum RP, Spitzweg C, Grohé C, Presselt N, Stremmel C, et
al: Neuroendocrine tumors of the bronchopulmonary system (typical
and atypical carcinoid tumors): Current strategies in diagnosis and
treatment. Conclusions of an expert meeting February 2011 in
Weimar, Germany. Oncol Res Treat. 37:266–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pareja F and D'Alfonso TM: Neuroendocrine
neoplasms of the breast: A review focused on the updated World
Health Organization (WHO) morphologic classification. Br J.
26:1160–1167. 2020.PubMed/NCBI
|
|
26
|
Adegbola T, Connolly CE and Mortimer G:
Small cell neuroendocrine carcinoma of the breast: A report of
three cases and review of the literature. J Clin Pathol.
58:775–778. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Roy M, Buehler DG, Zhang R, Schwalbe ML,
Baus RM, Salamat MS, Lloyd RV and Rosenbaum JN: Expression of
insulinoma-associated protein 1 (INSM1) and orthopedia homeobox
(OTP) in tumors with neuroendocrine differentiation at rare sites.
Endocr Pathol. 30:35–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhong E, Pareja F, Hanna MG, Jungbluth AA,
Rekhtman N and Brogi E: Expression of novel neuroendocrine markers
in breast carcinomas: A study of INSM1, ASCL1, and POU2F3. Human
Pathol. 127:102–111. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zombori T, Turkevi-Nagy S, Sejben A,
Juhász-Nagy G, Cserni G, Furák J, Tiszlavicz L, Krenács L and
Kővári B: The panel of syntaxin 1 and insulinoma-associated protein
1 outperforms classic neuroendocrine markers in pulmonary
neuroendocrine neoplasms. APMIS. 129:186–194. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kővári B, Turkevi-Nagy S, Báthori Á,
Fekete Z and Krenács L: Syntaxin 1: A novel robust immunophenotypic
marker of neuroendocrine tumors. Int J Mol Sci. 21:12132020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Turkevi-Nagy S, Báthori Á, Böcz J, Krenács
L, Cserni G and Kővári B: Syntaxin-1 and insulinoma-associated
protein 1 expression in breast neoplasms with neuroendocrine
features. Pathol Oncol Res. 27:16100392021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Juhlin CC, Zedenius J and Höög A: Clinical
routine application of the second-generation neuroendocrine markers
ISL1, INSM1, and secretagogin in neuroendocrine neoplasia: Staining
outcomes and potential clues for determining tumor origin. Endocr
Pathol. 31:401–410. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mohanty SK, Kim SA, DeLair DF, Bose S,
Laury AR, Chopra S, Mertens RB and Dhall D: Comparison of
metastatic neuroendocrine neoplasms to the breast and primary
invasive mammary carcinomas with neuroendocrine differentiation.
Mod Pathol. 29:788–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ang D, Ballard M, Beadling C, Warrick A,
Schilling A, O'Gara R, Pukay M, Neff TL, West RB, Corless CL and
Troxell ML: Novel mutations in neuroendocrine carcinoma of the
breast: Possible therapeutic targets. Appl Immunohistochem Mol
Morphol. 23:97–103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martinez EO, Jorns JM, Kong AL, Kijak J,
Lee WY, Huang CC and Cortina CS: Primary breast neuroendocrine
tumors: An analysis of the national cancer database. Ann Surg
Oncol. 29:6339–6346. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Castellanos MR, Fanous E, Thaker R, Flory
MJ, Seetharamu N, Dhar M, Starr A and Strange TJ: Expression
patterns and clinical significance of estrogen receptor in
non-small cell lung cancer. Pathol Res Pract. 241:1542982023.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mohanty SK, Kim SA, DeLair DF, Bose S,
Laury AR, Chopra S, Mertens RB and Dhall D: Comparison of
metastatic neuroendocrine neoplasms to the breast and primary
invasive mammary carcinomas with neuroendocrine differentiation.
Mod Pathol. 29:788–798. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Perry KD, Reynolds C, Rosen DG, Edgerton
ME, T Albarracin C, Gilcrease MZ, Sahin AA, Abraham SC and Wu Y:
Metastatic neuroendocrine tumour in the breast: A potential mimic
of in-situ and invasive mammary carcinoma. Histopathology.
59:619–630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Liu C, Zheng C, Ren Q, Wang Q,
Gao X, He Y, Wu J, Chen G, Li X and Ma Z: Efficacy of neoadjuvant
endocrine therapy in patients with poorly differentiated
neuroendocrine carcinoma of the breast: A case report. Medicine
(Baltimore). 99:e226522020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wei Y, Ke X, Yu J, Jing Q, Bu H, Zeng X
and Wei B: Clinical and genomic analyses of neuroendocrine
neoplasms of the breast. Mod Pathol. 35:495–505. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Marchiò C, Geyer FC, Ng CK, Piscuoglio S,
De Filippo MR, Cupo M, Schultheis AM, Lim RS, Burke KA,
Guerini-Rocco E, et al: The genetic landscape of breast carcinomas
with neuroendocrine differentiation. J Pathol. 241:405–419. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bean GR, Najjar S, Shin SJ, Hosfield EM,
Caswell-Jin JL, Urisman A, Jones KD, Chen YY and Krings G: Genetic
and immunohistochemical profiling of small cell and large cell
neuroendocrine carcinomas of the breast. Mod Pathol. 35:1349–1361.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vranic S, Palazzo J, Sanati S, Florento E,
Contreras E, Xiu J, Swensen J and Gatalica Z: Potential novel
therapy targets in neuroendocrine carcinomas of the breast. Clin
Breast Cancer. 19:131–136. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sagan OA, Rothstein A, Jambunathan B,
Hadziahmetovic M, Antoniolli A and Rashid MH: Case report:
Neuroendocrine breast carcinoma with a germline EGFR T790M
mutation. Front Oncol. 13:11768682023. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Acar A, Tolan HK, Ozbagriacik M and
Ezberci F: Primary neuroendocrine carcinoma of the breast: A 5-year
experiences. Ann Ital Chir. 91:23–26. 2020.PubMed/NCBI
|
|
46
|
Irelli A, Sirufo MM, Morelli L, D'Ugo C,
Ginaldi L and De Martinis M: Neuroendocrine Cancer of the Breast: A
Rare Entity. J Clin Med. 9:14522020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gallo M, Campione S, Di Vito V, Fortunati
N, Lo Calzo F, Messina E, Ruggeri RM, Faggiano A and Colao AAL:
Primary neuroendocrine neoplasms of the breast: Still open issues.
Front Endocrinol (Lausanne). 11:6102302021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Frame MT, Gohal J, Mader K and Goodman J:
Primary small cell carcinoma of the breast: An approach to medical
and surgical management. Cureus. 15:e479812023.PubMed/NCBI
|
|
49
|
Kontogeorgos G, Thodou E and Choreftaki T:
Investigation of somatostatin receptor profile of neuroendocrine
carcinomas of the breast. Pathol Res Pract. 216:1530662020.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Harris PE and Zhernosekov K: The evolution
of PRRT for the treatment of neuroendocrine tumors; what comes
next? Front Endocrinol (Lausanne). 13:9418322022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang J, Wei B, Albarracin CT, Hu J,
Abraham SC and Wu Y: Invasive neuroendocrine carcinoma of the
breast: A population-based study from the surveillance,
epidemiology and end results (SEER) database. BMC Cancer.
14:1472014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yang L, Roy M, Lin H, Shen Y, Albarracin
C, Huo L, Chen H, Wei B, Bedrosian I, Bu H and Wu Y: Validation of
prognostic significance of the proposed uniform classification
framework in neuroendocrine neoplasms of the breast. Breast Cancer
Res Treat. 186:403–415. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xia L, Lai J, Liu X, Kong F, Qiu S, Hu H,
Zhu S and Cao J: Epidemiological and survival outcomes of
neuroendocrine carcinoma of the breast: A SEER data analysis.
Transl Cancer Res. 12:1951–1962. 2023. View Article : Google Scholar : PubMed/NCBI
|
